Nearly two dozen antibody drug conjugates (ADCs) have now been approved worldwide and revenues were already well into the ...

The latest in a trend of companies stepping back from cell and gene therapies amid regulatory uncertainty and manufacturing ...

Ventus has entered a multi-year partnership with Roche’s Genentech for the discovery and optimisation of new small-molecule ...

The results strengthen Jiangsu Hengrui’s dominance in the Chinese HCC market, showing potential for camrelizumab and ...

Health Canada has granted conditional approval for Gilead Sciences’ Lyvdelzi for PBC patients who have difficulty with ...

Merck KGaA could now have a head start in the race to market Precem-TcT, which could become the first widely approved ADC in ...

Novo Nordisk will hold a meeting to elect new board members following a disagreement between the board and its majority shareholder.

Gibson, Dunn & Crutcher and White & Case have emerged as the foremost legal advisers for mergers and acquisitions (M&A) in ...

Morgan Stanley has secured the leading position as a financial adviser by deal value in South & Central America's M&A sector.

JP Morgan and Rothschild & Co have emerged as the top mergers and acquisitions (M&A) financial advisers in the Middle East & ...

In the realm of M&A, Skadden, Arps, Slate, Meagher & Flom, and Veirano Advogados have emerged as the top legal advisers in ...

These Phase III results could enhance uptake of Eli Lilly's Verzenio alongside ET in the adjuvant breast cancer setting, if ...